Co-Diagnostics reported a gross margin of -7.23% and a net margin of -2,229.35% for the quarter ended Sep 2026. These financial ratios cover 41 quarters of results from Jun 2016 through Sep 2026, standardized by Business Quant from the company’s SEC filings.
| RatiosRatios | Jun2016 | Sep2016 | Dec2016 | Jun2017 | Sep2017 | Dec2017 | Mar2018 | Jun2018 | Sep2018 | Dec2018 | Mar2019 | Jun2019 | Sep2019 | Dec2019 | Mar2020 | Jun2020 | Sep2020 | Dec2020 | Mar2021 | Jun2021 | Sep2021 | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 | Sep2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Profitability | |||||||||||||||||||||||||||||||||||||||||
| Gross Margin | 87.81% | 85.54% | 81.78% | 84.93% | 63.20% | 16.57% | -132.09% | 89.59% | 16.52% | 49.88% | 92.02% | 53.61% | -70.81% | 57.06% | 80.29% | 81.92% | 46.05% | -32.76% | 72.73% | -7.23% | |||||||||||||||||||||
| EBT Margin | 50.21% | 57.71% | -68.24% | -68.23% | -1,786.99% | -1,331.52% | -5,640.45% | -329.49% | -304.98% | -1,985.51% | -285.25% | -1,508.91% | -7,392.85% | -14,959.66% | -4,737.46% | -4,851.71% | -9,934.54% | -6,261.92% | -3,770.89% | -2,229.17% | |||||||||||||||||||||
| EBIT Margin | 50.53% | 43.28% | -82.56% | -128.29% | -1,863.84% | -1,653.05% | -6,063.74% | -363.68% | -332.62% | -2,192.86% | -289.06% | -1,596.36% | -7,973.90% | -17,009.68% | -4,946.14% | -4,824.49% | -10,056.68% | -6,309.12% | -3,732.47% | -2,216.25% | |||||||||||||||||||||
| EBITDA Margin | 51.03% | 44.37% | -74.11% | -122.15% | -1,842.53% | -1,600.55% | -5,909.42% | -351.62% | -323.82% | -2,122.20% | -276.33% | -1,541.58% | -7,734.74% | -16,451.88% | -4,767.26% | -4,640.57% | -9,955.30% | -6,134.10% | -3,610.97% | -2,137.64% | |||||||||||||||||||||
| Operating Margin | 50.53% | 43.28% | -82.56% | -128.29% | -1,863.84% | -1,653.05% | -6,063.74% | -363.68% | -332.62% | -2,192.86% | -289.06% | -1,596.36% | -7,973.90% | -17,009.68% | -4,946.14% | -4,824.49% | -10,056.68% | -6,309.12% | -3,732.47% | -2,216.25% | |||||||||||||||||||||
| Net Margin | 36.75% | 51.61% | -53.48% | -26.72% | -1,563.02% | -956.11% | -4,508.87% | -243.47% | -412.82% | -1,990.37% | -286.03% | -1,512.37% | -7,387.37% | -14,983.53% | -4,745.02% | -4,049.27% | -9,755.05% | -6,262.27% | -3,782.43% | -2,229.35% | |||||||||||||||||||||
| FCF Margin | 23.32% | 32.64% | 22.83% | 17.44% | -307.04% | -1,012.94% | -3,086.23% | -244.26% | -147.48% | -1,900.73% | -199.59% | -1,154.81% | -5,561.02% | -17,576.88% | -5,333.55% | -4,113.14% | -2,398.92% | -5,473.16% | -4,406.96% | -2,014.62% | |||||||||||||||||||||
| Efficiency | |||||||||||||||||||||||||||||||||||||||||
| Inventory AverageInventory Avg. | 2.65M | 3.45M | 4.80M | 5.07M | 5.38M | 5.30M | 4.99M | 4.61M | 3.09M | 1.61M | 1.51M | 1.36M | 1.17M | 1.08M | 1.08M | 1.09M | 1.04M | 0.92M | 0.84M | 0.76M | |||||||||||||||||||||
| Assets AverageAssets Avg. | 132.70M | 165.59M | 166.00M | 154.34M | 135.46M | 120.04M | 114.90M | 110.74M | 102.00M | 91.00M | 83.69M | 76.54M | 67.97M | 59.36M | 50.81M | 45.60M | 34.74M | 23.12M | 19.05M | 14.69M | |||||||||||||||||||||
| Equity AverageEquity Avg. | 117.32M | 141.09M | 146.09M | 139.71M | 124.73M | 112.57M | 107.03M | 101.46M | 92.53M | 81.96M | 75.38M | 68.09M | 58.83M | 50.68M | 44.09M | 40.05M | 30.01M | 18.34M | 14.38M | 11.07M | |||||||||||||||||||||
| Invested CapitalInvested Cap. | 148.00M | 144.76M | 135.24M | 114.82M | 110.91M | 104.20M | 100.28M | 86.42M | 79.21M | 73.28M | 64.68M | 54.79M | 48.39M | 41.53M | 40.14M | 21.29M | 16.90M | 13.50M | 10.14M | ||||||||||||||||||||||
| Asset Utilization RatioAsset Util. | 0.74 | 0.61 | 0.47 | 0.34 | 0.25 | 0.10 | 0.06 | 0.04 | 0.07 | 0.07 | 0.11 | 0.10 | 0.06 | 0.06 | 0.02 | 0.01 | 0.02 | 0.03 | 0.04 | 0.06 | |||||||||||||||||||||
| Leverage & Solvency | |||||||||||||||||||||||||||||||||||||||||
| Interest Coverage RatioInterest Cover | |||||||||||||||||||||||||||||||||||||||||
| Debt Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | 0.02 | 0.02 | 0.03 | 0.04 | 0.05 | 0.06 | ||||||||||||||||||||||
| Times Interest Earned | |||||||||||||||||||||||||||||||||||||||||
| Valuation | |||||||||||||||||||||||||||||||||||||||||
| Price to EarningsP/E | 247.15 | 155.67 | 203.03 | 196.32 | |||||||||||||||||||||||||||||||||||||
| Price to SalesP/S | 92.56 | 62.66 | 72.68 | 55.95 | 68.21 | 112.21 | 140.53 | 209.29 | 183.10 | 157.38 | 130.97 | 163.55 | 189.96 | 89.27 | 302.83 | 769.92 | 10.83 | 5.84 | 20.97 | 9.08 | |||||||||||||||||||||
| Price to BookP/B | 67.38 | 42.65 | 39.35 | 22.06 | 20.38 | 12.29 | 9.91 | 9.80 | 14.57 | 13.41 | 16.53 | 18.77 | 13.80 | 6.58 | 7.47 | 9.93 | 0.33 | 0.26 | 1.19 | 0.83 | |||||||||||||||||||||
| Enterprise Value | 8,970.48M | 6,203.22M | 5,589.34M | 2,890.90M | 2,252.71M | 1,284.80M | 956.13M | 911.51M | 1,188.71M | 1,000.99M | 1,151.78M | 1,159.70M | 713.96M | 290.75M | 290.57M | 379.59M | -5.14M | -4.04M | 11.48M | 7.08M | |||||||||||||||||||||
| EV to EBIT | 194.74 | 136.17 | 188.73 | 305.91 | |||||||||||||||||||||||||||||||||||||
| EV to EBITDA | 193.33 | 134.65 | 183.35 | 274.36 | |||||||||||||||||||||||||||||||||||||
| Market Capitalization | 9,060.34M | 6,300.65M | 5,685.34M | 2,977.39M | 2,333.97M | 1,360.08M | 1,025.27M | 974.94M | 1,247.26M | 1,050.95M | 1,196.66M | 1,197.37M | 743.70M | 312.23M | 303.93M | 391.03M | 6.74M | 4.19M | 15.12M | 7.80M | |||||||||||||||||||||
| Price to FCFP/FCF | 224.20 | 176.53 | 230.59 | 209.66 | 453.97 | ||||||||||||||||||||||||||||||||||||
| EV to FCF | 221.98 | 173.80 | 226.69 | 203.57 | 438.17 | ||||||||||||||||||||||||||||||||||||
| EV to CFO | 218.36 | 169.41 | 216.24 | 187.03 | 342.94 | ||||||||||||||||||||||||||||||||||||
| Return Ratios | |||||||||||||||||||||||||||||||||||||||||
| Return on Sales [ROS]ROS | 50.53% | 43.28% | -82.56% | -128.29% | -1,863.84% | -1,653.05% | -6,063.74% | -363.68% | -332.62% | -2,192.86% | -289.06% | -1,596.36% | -7,973.90% | -17,009.68% | -4,946.14% | -4,824.49% | -10,056.68% | -6,309.12% | -3,732.47% | -2,216.25% | |||||||||||||||||||||
| Return on Capital Employed [ROCE]ROCE | 38.36% | 29.86% | 18.59% | 6.37% | -20.50% | -40.16% | -49.74% | -53.96% | -44.37% | -50.18% | -49.37% | -56.54% | -66.08% | -71.09% | -82.28% | -84.78% | -160.78% | -269.80% | -302.59% | -395.92% | |||||||||||||||||||||
| Return on Invested Capital [ROIC]ROIC | 16.92% | 6.23% | -16.30% | -32.87% | -40.39% | -45.36% | -42.41% | -51.29% | -50.76% | -57.99% | -67.10% | -74.38% | -86.20% | -84.02% | -157.89% | -257.51% | -311.45% | -404.24% | |||||||||||||||||||||||
| Return on Assets [ROA]ROA | 27.63% | 24.44% | 16.87% | 9.83% | -10.51% | -26.27% | -32.77% | -38.15% | -34.78% | -43.01% | -45.14% | -54.20% | -54.97% | -60.24% | -71.30% | -71.26% | -136.19% | -211.21% | -247.78% | -323.80% | |||||||||||||||||||||
| Return on Equity [ROE]ROE | 31.25% | 28.69% | 19.17% | 10.86% | -11.42% | -28.01% | -35.18% | -41.63% | -38.34% | -47.75% | -50.12% | -60.93% | -63.52% | -70.55% | -82.16% | -81.14% | -157.66% | -266.33% | -328.23% | -429.77% |
Pull Co-Diagnostics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=CODX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "CODX", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=CODX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();